Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial Academic Article

authors

  • Chevli, K. Kent
  • Shore, Neal D.
  • Trainer, Andrew
  • Smith, Angela B.
  • Saltzstein, Daniel
  • Ehrlich, Yaron
  • Raman, Jay D.
  • Friedman, Boris
  • D’Anna, Richard
  • Morris, David
  • Hu, Brian
  • Tyson, Mark
  • Sankin, Alexander
  • Kates, Max
  • Linehan, Jennifer
  • Scherr, Douglas
  • Kester, Steven
  • Verni, Michael
  • Chamie, Karim
  • Karsh, Lawrence, MD, FACS, CPI
  • Cinman, Arnold
  • Meads, Andrew
  • Lahiri, Soumi
  • Malinowski, Madlen
  • Gabai, Nimrod
  • Raju, Sunil
  • Schoenberg, Mark
  • Seltzer, Elyse
  • Huang, William C.

Publication Date

  • 2022

webpage

published in

Digital Object Identifier (DOI)

number of pages

  • 8

start page

  • 61

end page

  • 69

volume

  • 207

issue

  • 1